LB
The startup specializes in droplet microfluidics technology to facilitate the detection and selection of living biological cells, including therapeutic antibody producers and rare immune cells. This approach enables life science researchers to analyze biological samples at the single-cell level with increased speed and precision, addressing the limitations of conventional manipulation techniques.
Updated 3 months ago
Funding
$2.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup specializes in droplet microfluidics technology to facilitate the detection and selection of living biological cells, including therapeutic antibody producers and rare immune cells. This approach enables life science researchers to analyze biological samples at the single-cell level with increased speed and precision, addressing the limitations of conventional manipulation techniques.